Skip to main content
. 2022 Nov 19;7:379. doi: 10.1038/s41392-022-01243-0

Fig. 1.

Fig. 1

Organelle-targeted therapy boosts cancer treatment outcomes by allowing for maximum accumulation of therapeutic agents in targets, triggering specific cell death pathways